Form 4 for ZBH Zimmer Biomet
Accepted 2024-06-04 00:00:00 ET · period of report 2024-05-31 · accession 0001062993-24-011819 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-04 | 2024-05-31 | ZBH | Yi Sang | Group Pres, Asia Pacific | S - Sale | $114.69 | -12.9K | 5,322 | -71% | -$1.47M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-31 | S | D | 12,857 | $114.69 | 5,322 | D | — | — | (F1) Reflects the weighted average price of 12,857 common shares sold by the reporting person in multiple transactions on May 31, 2024 with sale prices ranging from $114.64 to 114.79 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |